medigraphic.com
ISSN 1561-3011 (Electronic)

2016, Number 4

Next >>

Rev Cubana Invest Bioméd 2016; 35 (4)

Clinical and epidemiological characterization of urolithiasis in a rural area of Artemisa province

Bacallao MRA, Victores AI, Mañalich CR, Gutiérrez GF, Llerena FB, Almaguer LM

Language: Spanish
References: 23
Page: 300-310
PDF size: 220.91 Kb.


ABSTRACT

Introduction: Urolithiasis occurs very frequently and has common relapses, it favors renal functional deterioration and the management is costly.
Objective: To find out the prevalence, the frequency of relapses, the age at diagnosis and the risk factors for lithiasis in people living in "Eduardo Garcia Lavandero" community in Artemisa province.
Methods: Cross-sectional, descriptive and observational study conducted from September 2012 to January 2013. The whole information was processed with SPSS version 22 package. Primary data for the study was collected from survey carried out in the general population and from an interview and a dietary survey administered to lithiatis patients The rate of prevalence of this disease was estimated and the study used the frequency distribution analysis, the summary statistics and the homogeneity test.
Results: Two thousand and two hundred individuals, 1087 (49.4 %) males and 1113 (50.6 %) females were surveyed. One hundred one people with lithiasis were identified, for a prevalence rate of 4.59 per 100 inhabitants, aged 46.5 years as average and 69 (68.3 %) were Caucasians. In the study group, 47.5 % suffered relapses whereas the the most common age at diagnosis was 20 to 29 years (38.9 %). The most used diagnostic means was echography (57.4 %). High oxalate intake was the most frequent risk factor (99 %) whereas herbal medicine was the most used treatment (67.3). In the last two years, 18 patients had been hospitalized (15.9 %) due to this disease.
Conclusions: Urolithiasis is highly prevalent and recurrent. The most used diagnostic means was echography and the medical treatment prevailed, mainly the herbal medicine.


REFERENCES

  1. Stamatelou KK, Francis ME, Jones CA. Times trends in report prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23.

  2. Castiglione V, Jouret F, Bruyère O, Dubois B, Thomas A, Waltregny D, et al. Epidemiology of urolithiasis in Belgium on the basis of a morpho-constitutional classification. Nephrol Ther. 2015 Feb;11(1):42-9.

  3. Seitz C, Fajkovic H. Epidemiological gender-specific aspects in urolithiasis. World J Urol. Oct. 2013;31(5):1087-92.

  4. Sánchez-Martín FM, Millán Rodríguez F, Esquena Fernández S, Segarra Tomás J, Rousaud Barón F, Martínez-Rodríguez R, et al. Incidencia y prevalencia de la urolitiasis en España: Revisión de los datos originales disponibles hasta la actualidad. Actas Urol Esp [revista en la Internet]. 2007 Mayo [citado 2015 Jul 03];31(5):511-520. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062007000500011&lng=es

  5. Fisang C, Anding R, Müller SC, Latz S, Laube N. Urolithiasis-an Interdisciplinary Diagnostic, Therapeutic and Secondary Preventive Challenge. Dtsch Arztebl Int. 2015 Feb;112(6):83-91.

  6. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2009;16:5-10.

  7. Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens. 2013 Jul;22(4):390-6.

  8. Pérez-Oliva J, Pérez R, Herrera R, Almaguer M, Brisquet E. Terapia renal de reemplazo dialítico en Cuba: tendencia durante los últimos 10 años. Rev Hab Cienc Méd. 2012;11(3):424-33.

  9. Okamoto N, Aruga S, Matsuzaki S. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol. 2007;14:344.

  10. Reyes L, Mirabal M, Strusser R, Almaguer M. Comportamiento clínico-epidemiológico de la urolitiasis en un área rural del Caribe. Arch Esp. Urolo. 2002;55(5):527-34.

  11. Oficina Nacional de Estadísticas. Censo de población y viviendas Cuba-2012. Resumen adelantado. Informe Nacional. La Habana: Oficina Nacional de Estadísticas; 2014.

  12. Johnson CM, Wilson DM, O'Fallon WM. Renal stone epidemiology: A 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624-31.

  13. Herrera R, Almaguer M, Chipi J, Toirac X, Martínez O, Castellanos O, et al. Detection of markers of cardiovascular and renal risk in Cuba: Isle of Youth Study (ISYS). Nephron Clin Pract. 2011;117(4):c353-62.

  14. Jiménez Acosta S, Díaz ME, Barroso I, Bonet M, Cabrera A, Wong I, et al. Estado nutricional de la población cubana adulta. Rev Esp Nutr Comunitaria. 2005;11(1):18-26.

  15. Schneider H, Dietrich E, Venetz W. Trends and Stabilization up to 2022 in Overweight and Obesity in Switzerland, Comparison to France, UK, US and Australia. Int J Environl Res Public Health. 2010;7(2):460-72.

  16. Bacallao Méndez RA, Madrid Mancia C, Mañalich Comas R, Gutiérrez García F, Badell Moore A. Trastornos metabólicos renales en pacientes cubanos adultos con litiasis urinarias. Rev Cubana Med [revista en la Internet]. 2014 Dic [citado 2015 Jun 24];53(4):456-67. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232014000400009&lng=es

  17. Ahmad F, Nada MO, Farid AB, Haleem MA, Razack SM. Epidemiology of urolithiasis with emphasis on ultrasound detection: a retrospective analysis of 5371 cases in Saudi Arabia. Saudi J Kidney Dis Transpl. 2015 Mar;26(2):386-91.

  18. Reyes L, Mirabal M, Mañalich R, Almaguer M. Estudio comparativo del comportamiento clínico epidemiológico de la urolitiasis en dos poblaciones diferentes de Cuba. Rev Port Nefrol Hipert. 2004;18(3):155-65.

  19. Lieske JC, Pena de La Vega LS, Slezak JM. Renal Stone epidemiology in Rochester, Minnesota an update. Kidney Int. 2006;69:760.

  20. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999;81(supl 1):26-60.

  21. Parry ES, Lister IS. Sunlight and hypercalciuria. Lancet. 1975;1:1063-5.

  22. Lotan Y, Daudon M, Bruyere F, Talaska G, Strippoli G, Johnson RJ, et al. Impact of fluid intake in the prevention of urinary system diseases: a brief review. Curr Opin Nephrol Hypertens. 2013;22(Suppl 1):S1-10.

  23. Linder BJ, Rangel LJ, Krambeck AE. The effect of work location on urolithiasis in health care professionals. Urolithiasis. 2013 Aug;41(4):327-31.




2020     |     www.medigraphic.com